Vertex Pharmaceuticals Inc / Ma

ROYAL LONDON ASSET MANAGEMENT LTD VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

273,433

Value ($000)

123,964

Weight

0.3%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	123,964	0.3%	273,433	12/31/2025
2025 Q3	11/13/2025	108,561	0.2%	277,196	9/30/2025
2025 Q2	8/14/2025	126,145	0.3%	283,345	6/30/2025
2025 Q1	5/13/2025	162,726	0.4%	335,642	3/31/2025
2024 Q4	2/11/2025	146,292	0.4%	363,278	12/31/2024
2024 Q3	11/14/2024	168,885	0.4%	363,130	9/30/2024
2024 Q2	8/7/2024	173,309	0.4%	369,750	6/30/2024
2024 Q1	5/14/2024	173,995	0.4%	416,246	3/31/2024
2023 Q4	3/1/2024	157,793	0.5%	387,803	12/31/2023
2023 Q3	11/14/2023	135,823	0.4%	390,508	9/30/2023
2023 Q2	8/11/2023	109,594	0.4%	311,507	6/30/2023
2023 Q1	5/15/2023	80,429	0.3%	255,273	3/31/2023
2022 Q4	2/9/2023	26,235	0.1%	90,877	12/31/2022
2022 Q3	11/14/2022	25,040	0.1%	86,482	9/30/2022
2022 Q2	9/6/2022	25,492	0.1%	90,423	6/30/2022
2022 Q1	9/6/2022	23,426	0.1%	89,765	3/31/2022
2021 Q4	10/18/2022	19,061	0.1%	86,787	12/31/2021
2021 Q3	10/18/2022	16,472	0.1%	90,792	9/30/2021
2021 Q2	10/18/2022	19,018	0.1%	94,307	6/30/2021
2021 Q1	10/17/2022	21,395	0.1%	99,526	3/31/2021
2020 Q4	1/29/2021	22,767	0.1%	96,377	12/31/2020
2020 Q3	11/4/2020	26,777	0.2%	99,043	9/30/2020
2020 Q2	7/31/2020	28,250	0.2%	99,059	6/30/2020
2020 Q1	5/1/2020	23,841	0.2%	102,824	3/31/2020
2019 Q4	2/5/2020	22,523	0.2%	102,824	12/31/2019
2014 Q1	5/21/2014	3,724	0.1%	54,979	3/31/2014
2013 Q4	1/27/2014	4,209	0.1%	53,816	12/31/2013